HPV検査およびPAP検査の世界市場予測（～2020）...市場調査レポートについてご紹介

1 Introduction (Page No. – 13)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 16)
2.1 HPV testing Market Size Estimation
2.2 HPV testing Market Breakdown and Data Triangulation
2.2.1 Key Data From Secondary Sources
2.2.2 Key Data From Primary Sources
2.2.2.1 Key Industry Insights
2.2.3 Assumptions

3 Executive Summary (Page No. – 23)

4 Premium Insights (Page No. – 26)
4.1 Market Overview
4.2 Market, By Test Type
4.3 Market, By Test Type and End User
4.4 Market, By Region

5 Market Overview (Page No. – 28)
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Increasing Number of Cervical Cancer Cases and Growing Aging Population
5.3.1.2 Increasing Awareness of Cervical Cancer Screening Programs
5.3.1.3 Government Initiatives and Funding
5.3.2 Restraints
5.3.2.1 Changes in Regulatory Guidelines for Cervical Cancer Screening
5.3.2.2 HPV Vaccination
5.3.3 Opportunity
5.3.3.1 Introduction of HPV Primary Screening Tests
5.3.4 Challenge
5.3.4.1 Uncertain Reimbursement Scenario

6 HPV Testing and PAP Test Market, By Test Type (Page No. – 37)
6.1 Introduction
6.2 HPV Testing
6.3 Follow-Up HPV Testing
6.4 Co-Testing
6.5 Primary HPV Testing
6.6 PAP Test

7 PAP Test Market, By Application (Page No. – 47)
7.1 Introduction
7.1.1 Cervical Cancer Screening
7.1.2 Vaginal Cancer Screening

8 HPV Testing and PAP Test Market, By End User (Page No. – 53)
8.1 Introduction
8.2 Laboratories
8.3 Hospitals
8.4 Physicians’ Offices and Clinics

9 HPV Testing and PAP Test Market, By Region (Page No. – 61)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Rest of Asia-Pacific
9.5 Rest of the World

10 Competitive Landscape (Page No. – 92)
10.1 Overview
10.2 Market Share Analysis, Global HPV testing Market
10.2.1 Product Approvals and Licenses
10.2.2 New Product Launches
10.2.3 Agreements, Collaborations, and Partnerships
10.2.4 Acquisitions
10.2.5 Expansions

11 Company Profile (Page No. – 100)
(Overview, Products and Services, Financials, Strategy & Development)*
11.1 Introduction
11.2 Abbott Laboratories
11.3 Qiagen N.V.
11.4 Roche Diagnostics
11.5 Hologic, Inc.
11.6 Becton, Dickinson and Company
11.7 Quest Diagnostics
11.8 Onco Health Corporation
11.9 Seegene, Inc.
11.10 Femasys Inc.
11.11 Arbor Vita Corporation

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 120)
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Introducing RT: Real-Time Market Intelligence
12.4 Available Customizations
12.5 Related Reports